30
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Advances in the Treatment of Multiple Myeloma: The Role of Thalidomide

&
Pages 291-298 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Miki Nakamura, Tomomi Gotoh, Yutaka Okuno, Hiro Tatetsu, Takashi Sonoki, Shima Uneda, Masataka Mori, Hiroaki Mitsuya & Hiroyuki Hata. (2006) Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells. Leukemia & Lymphoma 47:3, pages 531-539.
Read now
Emmanuel Laffitte & Jean Revuz. (2004) Thalidomide: an old drug with new clinical applications. Expert Opinion on Drug Safety 3:1, pages 47-56.
Read now

Articles from other publishers (6)

H. Miles Prince, Michael Adena, Dell Kingsford Smith & Judy Hertel. (2007) Efficacy of single-agent bortezomib vs. single-agent thalidomide in patients with relapsed or refractory multiple myeloma: a systematic comparison. European Journal of Haematology 79:2, pages 93-99.
Crossref
. 2007. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose. Haddad and Winchester's Clinical Management of Poisoning and Drug Overdose 927 941 .
Murali Chintagumpala, Susan M. Blaney, Lisa R. Bomgaars, Aleksander Aleksic, John F. Kuttesch, Renee A. Klenke & Stacey L. Berg. (2004) Phase I and Pharmacokinetic Study of Thalidomide With Carboplatin in Children With Cancer. Journal of Clinical Oncology 22:21, pages 4394-4400.
Crossref
Joan E. Smallshaw, Elaine Coleman, Camelia Spiridon & Ellen S. Vitetta. (2004) The Generation and Anti-Myeloma Activity of a Chimeric Anti-CD54 Antibody, cUV3. Journal of Immunotherapy 27:6, pages 419-424.
Crossref
Arun Rajagopal, Savita Kala & Eduardo Bruera. (2003) Possible exacerbation of adrenal suppression from intrathecal morphine in a patient receiving pulsed dexamethasone for multiple myeloma. Journal of Pain and Symptom Management 26:3, pages 786-788.
Crossref
. (2003) Current Awareness in Hematological Oncology. Hematological Oncology 21:2, pages 91-98.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.